UTERINE MYOMAS
Keywords:
Submucous myomas , subserous myomas , interstitial myomas ,hypermenorrhea, menopause , reproductive age , esterogenic, gestogenic , tumor malignancy .Abstract
This article is written on the basis of the national standard of the Ministry of health of the Republic of Uzbekistan , which talks about measures to properly diagnose , treat and prevent patients with uterine myomas at present . Among women of reproductive age, the incidence of the disease reaches 70%. The median age for detecting uterine fibroids is 32-34 years, and the highest level of the disease occurs at the beginning of menopause. Currently, there is an increase in the incidence of uterine fibroids in young women under 30 years of age who have not performed their reproductive function.
Downloads
References
Adamyan L. V. Sostoyanie reproductivnoy system u bolnix dobrokachestvennimi opuxolyami vnutrennix genitalia I principle vosstanovitelnogo lechenia / / Moscow. – 1985. Moscow.
El-Balat A. et al. Modern Myoma Treatment in the Last 20 years: a Review of the Literature
// BioMed research international. – 2018. - T. 2018.
Pérez-López F. R. et al. Not position statement: management of uterine fibroids
// Maturitas. – 2014. - T. 79. – №. 1. - S. 106-116.
Kubik-Huch R. A. et al. European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas //European radiology. – 2018. - T. 28. – №. 8. - S. 3125-3137.
Grings A. O. et al. Protein expression of estrogen receptors α and β and aromatase in myometrium and uterine leiomyoma //gynecological and obstetric investigation. – 2012. - T. 73. –№. 2. - S. 113-117.
Markowski D. N. et al. HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications //Anticancer research. – 2011. - T. 31. – №. 3. - S. 753-761.
Ciavattini A. et al. Uterine fibroids: pathogenesis and interactions with endometrium and endometrial junction //Obstetrics and gynecology international. – 2013. - T. 2013.
Mittal P. et al. Med12 gain-of-function mutation causes leiomyomas and genomic instability
//The Journal of clinical investigation. – 2015. - T. 125. – №. 8. - S. 3280-3284.
Osinovskaya N. S. et al. Frequency and spectrum of MED12 exon 2 mutations in multiple versus solitary uterine leiomyomas from Russian patients //International journal of gynecological pathology. – 2016. - T. 35. – №. 6. - S. 509-515.
Tal R., Segars J. H. The role of angiogenic factors in fibroid pathogenesis: potential implementations for future therapy //Human reproduction update. – 2013. - T. 20. – №. 2. - S. 194-216.
Sidorova I. S. I Dr. Sovremennoe sostoyanie voprosa O pathogeneze, Kline, diagnostics I lechenii fibroids matki U jentshin reproductivnogo vozrasta //Akusherstvo, gynecology I reproduction. – 2012. - T. 6. – №. 4.
Ren Y. et al. Different effects of epidermal growth factor on smooth muscle cells derived from human myometrium and from leiomyoma //Fertility and sterility. – 2011. - T. 96. – №. 4. - S. 1015- 1020.
Plewka D. et al. Expression of VEGF isoforms and their receptors in uterine myomas//Gynaecologia polska. – 2016. - T. 87. – №. 3. - S. 166-177.
Baird D. D. et al. High cumulative evidence of uterine leiomyoma in black and white women: ultrasound evidence //American journal of obstetrics and gynecology. – 2003. - T. 188. – №. 1. - S. 100-107.
Chiaffarino F. et al. Alcohol consumption and risk of uterine myoma: a systematic review and meta analysis //PloS One. – 2017. - T. 12. – №. 11. - S. e0188355.
Serov V. N., Suxix G. T. Klinicheskie rekomendasii. Akusherstvo I gynecology / / m: GEOTAR-media.- 4-e izd.-2017. Moscow: problemi reproduktsii.
Donnez J., Donnez O., Dolmans M. M. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? // Fertility and Sterility. – 2014. - T. 102. – №. 3. - S. 640-648.
Worldwide A. A. M. I. G. AAGL practice report: practice guidelines for the management of hysteroscopic distending media: (replace hysteroscopic fluid monitoring guidelines. J Am Assoc Gynecol Laparosc. 2000; 7: 167–168.) / / Journal of minimally invasive gynecology. – 2013. - T. 20. –№. 2. - S. 137-148. SOGC clinical practice guideline, the Management of Uterine Leiomyomas, No. 318.
Stewart E. A. et al. Epidemiology of uterine fibroids: a systematic review //BJOG: An International Journal of Obstetrics & Gynaecology. – 2017. - T. 124. – №. 10. - S. 1501-1512.
Zepiridis L. I., Grimbizis G. F., Tarlatzis B. C. Infertility and uterine fibroids //Best Practice & Research Clinical Obstetrics & Gynaecology. – 2016. - T. 34. - S. 66-73.
Parazzini F., Tozzi L., Bianchi S. Pregnancy output and uterine fibroids //Best practice & research Clinical obstetrics & gynaecology. – 2016. - T. 34. - S. 74-84.
Munro M. G. et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age //International Journal of Gynecology & Obstetrics. – 2011. - T. 113. – №. 1. - S. 3-13.
Munro M. G. et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions //International Journal of Gynecology & Obstetrics. – 2018.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in the Journal of Applied Science and Social Science (JASSS) is protected by copyright. Authors retain the copyright to their work, and grant JASSS the right to publish the work under a Creative Commons Attribution License (CC BY). This license allows others to distribute, remix, adapt, and build upon the work, even commercially, as long as they credit the author(s) for the original creation.
